Executive Dysfunction in MCI: Subtype or Early Symptom

Ivar Reinvang1, Ramune Grambaite, Thomas Espeseth

  • 1Center for the Study of Human Cognition, Department of Psychology, University of Oslo, 0316 Oslo, Norway.

Insights

Executive function impairments, or executive MCI (eMCI), may signal early Alzheimer's Disease (AD). Changes in white matter integrity are sensitive markers for tracking AD progression in at-risk individuals.

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Neurology

Background:

  • Mild cognitive impairment (MCI) presents diverse forms, with amnestic MCI (aMCI) often preceding Alzheimer's Disease (AD).
  • Executive function impairments, termed executive MCI (eMCI), are linked to neurodegenerative conditions and can indicate future AD development.
  • Executive dysfunction is a significant prognostic factor in aMCI and a potential early indicator of AD pathophysiology.

Purpose of the Study:

  • To investigate the role of executive function deficits in the early detection and progression of Alzheimer's Disease.
  • To evaluate the sensitivity of white matter integrity changes compared to cortical atrophy in identifying eMCI.
  • To explore the utility of executive function as a cognitive marker in genetically high-risk populations for AD.

Main Methods:

  • Analysis of cognitive function, focusing on executive functions and attention.
  • Assessment of white matter integrity using advanced neuroimaging techniques.
  • Evaluation of cortical atrophy as a comparative measure.
  • Utilizing cognitive neuroscience paradigms in genetically defined high-risk groups.

Main Results:

  • Executive function impairments (eMCI) are frequently observed in aMCI and are significant for prognosis.
  • Changes in white matter integrity show higher sensitivity than cortical atrophy measures in detecting eMCI.
  • Cognitive neuroscience studies in high-risk groups suggest executive function changes are valuable markers for AD development.

Conclusions:

  • Executive function deficits, particularly in eMCI, are critical indicators in the early stages of neurodegeneration.
  • White matter integrity is a more sensitive biomarker than cortical atrophy for tracking early AD-related changes.
  • Executive function serves as a promising cognitive marker for monitoring AD progression, especially in at-risk populations.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the cerebellum's...